EDTUTC-4 New YorkLog in Sign up

IVBXF
INNOVENT BIOLOGICS INC
stockOTC

EODOct 2, 2026

12.80USD+2.334%(+0.29)396

IVBXF News

Day breaks

03:45 AM EDT2026 IMS Oral Presentation: Innovent Announces Updated Phase 1 Clinical Data of Trispecific Antibody IBI3003 (GPRC5D/BCMA/CD3) in Patients with Relapsed or Refractory Multiple Myeloma ·

PR Newswire

06:30 AM EDTJaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy ·

PR Newswire

06:30 AM EDTJaypirca® (pirtobrutinib) Approved in China for a New Indication in Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) Across All Lines of Therapy ·

PR Newswire

03:11 AM EDTInnovent expands Phase III MarsLight-11 trial to non-squamous NSCLC ·

Clinical Trials Arena

12:34 AM EDTHang Seng Index forms a highly bullish pattern as bottoming signs emerge ·

Invezz

08:00 PM EDTInnovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC ·

PR Newswire

08:00 PM EDTInnovent Announces Expansion of Global Phase 3 MarsLight-11 Study of IBI363/TAK-928 (Alpha-biased IL-2/PD-1 Bispecific Fusion Protein) in Immunotherapy-Resistant NSCLC to Include Patients with Non-Squamous NSCLC ·

PR Newswire

04:48 AM EDTInnovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting ·

PR Newswire

04:48 AM EDTInnovent to Present New Clinical Data of Next-gen IO and ADC Pipeline at the 2026 ESMO Annual Meeting ·

PR Newswire

08:32 AM EDTNuvation Bio rises on FDA label update for Ibtrozi ·

Seeking Alpha